A drug commonly prescribed to treat high blood pressure, could slow the progression of eye damage in people with type 1 diabetes, a new study has said.
By administering an antihypertensive, University of Minnesota Medical School researcher Michael Mauer, M.D. and colleagues were able to slow progression of diabetic eye damage in more than 65 percent of participants involved in the study.
Diabetes
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, symptoms, diagnosis, treatment, facts and a glossary on diabetes.
Advertisement
Three groups of participants were observed over the course of five years. Two groups were administered one of two antihypertensive medications, losartan or enalapril, and the last group, a placebo.
Mauer's study demonstrated that participants who were administered either enalapril or losartan experienced a significant slowing of the progression of diabetic eye injury, by 65 and 70 percent, respectively.
![Diabetic Diet Insulin : Sugar and Food]( "Diabetic Diet Insulin : Sugar and Food")
Encyclopedia section of medindia briefly explains about Insulin - Sugar and Food
"The secondary results of this study showed that people taking these antihypertensive medications experienced a substantially positive effect in slowing diabetic eye injury," said Mauer.
The study has been published in the July 2nd issue of The New England Journal of Medicine.
Source: ANI
RAS
Diabetic Diet Insulin : Sugar and Food
Encyclopedia section of medindia briefly explains about Insulin - Sugar and Food
Advertisement
"The secondary results of this study showed that people taking these antihypertensive medications experienced a substantially positive effect in slowing diabetic eye injury," said Mauer.
The study has been published in the July 2nd issue of The New England Journal of Medicine.
Source: ANI
RAS
Gestational diabetes
The condition is not caused by a lack of insulin, but by the action of hormones produced during pregnancy that blocks the action of insulin.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial